157 related articles for article (PubMed ID: 16596327)
1. Catechol-O-methyltransferase haplotypes and breast cancer among women on Long Island, New York.
Gaudet MM; Bensen JT; Schroeder J; Olshan AF; Terry MB; Eng SM; Teitelbaum SL; Britton JA; Lehman TA; Neugut AI; Ambrosone CB; Santella RM; Gammon MD
Breast Cancer Res Treat; 2006 Sep; 99(2):235-40. PubMed ID: 16596327
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive assessment of genetic variation of catechol-O-methyltransferase and breast cancer risk.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Garcia-Closas M
Cancer Res; 2006 Oct; 66(19):9781-5. PubMed ID: 17018638
[TBL] [Abstract][Full Text] [Related]
3. The impact of catechol-O-methyltransferase SNPs and haplotypes on treatment response phenotypes in major depressive disorder: a case-control association study.
Kocabas NA; Faghel C; Barreto M; Kasper S; Linotte S; Mendlewicz J; Noro M; Oswald P; Souery D; Zohar J; Massat I
Int Clin Psychopharmacol; 2010 Jul; 25(4):218-27. PubMed ID: 20531207
[TBL] [Abstract][Full Text] [Related]
4. The association of functional catechol-O-methyltransferase haplotypes with risk of Parkinson's disease, levodopa treatment response, and complications.
Bialecka M; Kurzawski M; Klodowska-Duda G; Opala G; Tan EK; Drozdzik M
Pharmacogenet Genomics; 2008 Sep; 18(9):815-21. PubMed ID: 18698234
[TBL] [Abstract][Full Text] [Related]
5. Oestrogen receptor alpha gene haplotype and postmenopausal breast cancer risk: a case control study.
Wedrén S; Lovmar L; Humphreys K; Magnusson C; Melhus H; Syvänen AC; Kindmark A; Landegren U; Fermér ML; Stiger F; Persson I; Baron J; Weiderpass E
Breast Cancer Res; 2004; 6(4):R437-49. PubMed ID: 15217512
[TBL] [Abstract][Full Text] [Related]
6. An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer.
Lavigne JA; Helzlsouer KJ; Huang HY; Strickland PT; Bell DA; Selmin O; Watson MA; Hoffman S; Comstock GW; Yager JD
Cancer Res; 1997 Dec; 57(24):5493-7. PubMed ID: 9407957
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.
Wang SS; Morton LM; Bergen AW; Lan EZ; Chatterjee N; Kvale P; Hayes RB; Chanock SJ; Caporaso NE
Hum Genet; 2007 Aug; 122(1):41-9. PubMed ID: 17497175
[TBL] [Abstract][Full Text] [Related]
8. Polymorphic catechol-O-methyltransferase gene and breast cancer risk.
Mitrunen K; Jourenkova N; Kataja V; Eskelinen M; Kosma VM; Benhamou S; Kang D; Vainio H; Uusitupa M; Hirvonen A
Cancer Epidemiol Biomarkers Prev; 2001 Jun; 10(6):635-40. PubMed ID: 11401913
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation of Cytochrome P450 1B1 (CYP1B1) and risk of breast cancer among Polish women.
Gaudet MM; Chanock S; Lissowska J; Berndt SI; Yang XR; Peplonska B; Brinton LA; Welch R; Yeager M; Bardin-Mikolajczak A; Sherman ME; Sutter TR; Garcia-Closas M
Pharmacogenet Genomics; 2006 Aug; 16(8):547-53. PubMed ID: 16847423
[TBL] [Abstract][Full Text] [Related]
10. Polymorphic catechol-O-methyltransferase gene, duration of estrogen exposure, and breast cancer risk: a nested case-control study in Taiwan.
Lin WY; Chou YC; Wu MH; Jeng YL; Huang HB; You SL; Chu TY; Chen CJ; Sun CA
Cancer Detect Prev; 2005; 29(5):427-32. PubMed ID: 16191465
[TBL] [Abstract][Full Text] [Related]
11. Breast cancer risk reduction and membrane-bound catechol O-methyltransferase genetic polymorphisms.
Ji Y; Olson J; Zhang J; Hildebrandt M; Wang L; Ingle J; Fredericksen Z; Sellers T; Miller W; Dixon JM; Brauch H; Eichelbaum M; Justenhoven C; Hamann U; Ko Y; Brüning T; Chang-Claude J; Wang-Gohrke S; Schaid D; Weinshilboum R
Cancer Res; 2008 Jul; 68(14):5997-6005. PubMed ID: 18632656
[TBL] [Abstract][Full Text] [Related]
12. Catechol-O-Methyltransferase (COMT) gene polymorphism and breast cancer risk in young women.
Bergman-Jungeström M; Wingren S
Br J Cancer; 2001 Sep; 85(6):859-62. PubMed ID: 11556837
[TBL] [Abstract][Full Text] [Related]
13. Association of COMT haplotypes and breast cancer risk in caucasian women.
Peterson NB; Trentham-Dietz A; Garcia-Closas M; Newcomb PA; Titus-Ernstoff L; Huang Y; Chanock SJ; Haines JL; Egan KM
Anticancer Res; 2010 Jan; 30(1):217-20. PubMed ID: 20150638
[TBL] [Abstract][Full Text] [Related]
14. Genetic polymorphisms of SULT1A1 and SULT1E1 and the risk and survival of breast cancer.
Choi JY; Lee KM; Park SK; Noh DY; Ahn SH; Chung HW; Han W; Kim JS; Shin SG; Jang IJ; Yoo KY; Hirvonen A; Kang D
Cancer Epidemiol Biomarkers Prev; 2005 May; 14(5):1090-5. PubMed ID: 15894657
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms and haplotypes in the cytochrome P450 17A1, prolactin, and catechol-O-methyltransferase genes and non-Hodgkin lymphoma risk.
Skibola CF; Bracci PM; Paynter RA; Forrest MS; Agana L; Woodage T; Guegler K; Smith MT; Holly EA
Cancer Epidemiol Biomarkers Prev; 2005 Oct; 14(10):2391-401. PubMed ID: 16214922
[TBL] [Abstract][Full Text] [Related]
16. Relationship between the Val158Met polymorphism of catechol O-methyl transferase and breast cancer.
Yim DS; Parkb SK; Yoo KY; Yoon KS; Chung HH; Kang HL; Ahn SH; Noh DY; Choe KJ; Jang IJ; Shin SG; Strickland PT; Hirvonen A; Kang D
Pharmacogenetics; 2001 Jun; 11(4):279-86. PubMed ID: 11434504
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of breast cancer risk in a multigenic model including low penetrance genes involved in xenobiotic and estrogen metabolisms.
Delort L; Satih S; Kwiatkowski F; Bignon YJ; Bernard-Gallon DJ
Nutr Cancer; 2010; 62(2):243-51. PubMed ID: 20099199
[TBL] [Abstract][Full Text] [Related]
18. Expression of cytochrome P450 1B1 and catechol-O-methyltransferase in breast tissue and their associations with breast cancer risk.
Wen W; Ren Z; Shu XO; Cai Q; Ye C; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2007 May; 16(5):917-20. PubMed ID: 17507616
[TBL] [Abstract][Full Text] [Related]
19. MGMT genotype modulates the associations between cigarette smoking, dietary antioxidants and breast cancer risk.
Shen J; Terry MB; Gammon MD; Gaudet MM; Teitelbaum SL; Eng SM; Sagiv SK; Neugut AI; Santella RM
Carcinogenesis; 2005 Dec; 26(12):2131-7. PubMed ID: 16014702
[TBL] [Abstract][Full Text] [Related]
20. Val158Met Polymorphism in catechol-O-methyltransferase gene associated with risk factors for breast cancer.
Hong CC; Thompson HJ; Jiang C; Hammond GL; Tritchler D; Yaffe M; Boyd NF
Cancer Epidemiol Biomarkers Prev; 2003 Sep; 12(9):838-47. PubMed ID: 14504192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
